ArticleCancer medicine2021

ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patients.

Anand Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.